Plantar involvement correlates with obesity, pain and impaired mobility in epidermolysis bullosa simplex: a retrospective cohort study

Background Epidermolysis bullosa simplex (EBS) is the most common type of EB, a group of rare genodermatoses. Affected individuals suffer from skin blistering and report a high disease burden. In some EBS subtypes, plantar keratoderma (PK) has been described. Objectives This study investigated the p...

Full description

Saved in:
Bibliographic Details
Published inJournal of the European Academy of Dermatology and Venereology Vol. 35; no. 10; pp. 2097 - 2104
Main Authors Reimer‐Taschenbrecker, A., Hess, M., Hotz, A., Fischer, J., Bruckner‐Tuderman, L., Has, C.
Format Journal Article
LanguageEnglish
Published England 01.10.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background Epidermolysis bullosa simplex (EBS) is the most common type of EB, a group of rare genodermatoses. Affected individuals suffer from skin blistering and report a high disease burden. In some EBS subtypes, plantar keratoderma (PK) has been described. Objectives This study investigated the presence and correlation of PK with body mass index, pain and mobility in EBS. Methods Individuals (n = 157) with genetically characterized EBS were included in this retrospective cohort study, and clinical data were collected over 16 years (referral patients to the largest German EB centre). Descriptive statistics and mixed linear models were used to assess correlations. Results PK was found in 75.8% of patients beginning at a mean age of 4.3 years. Both focal and diffuse PK were observed, and 60% of adults with localized and severe EBS were preobese or obese, with ˜30% of patients reporting severely reduced mobility. The presence of PK, especially diffuse PK, correlated significantly with local infections, obesity, pain and requirement of a wheelchair. Conclusion Along with treating skin fragility and blistering, PK should be considered a potential marker of increased morbidity and may represent a target of EBS therapy development.
Bibliography:The data within this manuscript were in part presented in a poster at the EB2020 World Congress in London, UK, 20‐23rd January 2020.
Conflicts of interest
None.
Declaration
The project was funded by a promotional award issued by the German Foundation for Pediatric Dermatology (Deutsche Stiftung Kinderdermatologie e.V.) to ART and by a grant provided by DEBRA international to ART and CH. ART was supported by the Berta‐Ottenstein‐Programme for Clinician Scientists, Faculty of Medicine, University of Freiburg. Open access funding provided by the DEAL project.
Funding source
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0926-9959
1468-3083
DOI:10.1111/jdv.17336